Allogeneic Stem Cell Therapy in Heart Failure

Summary

The present aim is to perform at clinical double-blind placebo-controlled Cardiology Stem Cell Centre - Adipose Stem Cells (CSCC\_ASC) study in heart failure patients to investigate the regenerative capacity of the CSCC\_ASC treatment.

Timeline

Start

2015-09

Primary completion

2021-07

Completion

2022-07

Publications

• Qayyum AA, Mouridsen M, Nilsson B, Gustafsson I, Schou M, Nielsen OW, Hove JD, Mathiasen AB, Jorgensen E, Helqvist S, Joshi FR, Johansen EM, Follin B, Juhl M, Hojgaard LD, Haack-Sorensen M, Ekblond A, Kastrup J. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure. ESC Heart Fail. 2023 Apr;10(2):1170-1183. doi: 10.1002/ehf2.14281. Epub 2023 Jan 13.

Drugs

Indications